Inari Medical, Inc. (NARI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2024-12-20

Inari Medical, Inc. (NARI) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every NARI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Inari Medical, Inc. (NARI)

SEC CIK	0001531048

Recent NARI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2024-12-20	Hykes Andrew	President and CEO	S — Open-market sale [10b5-1]	2.4K	$55.20	$132K	SEC
2024-12-20	Hykes Andrew	President and CEO	S — Open-market sale [10b5-1]	600	$55.65	$33K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	20.9K	$55.23	$1.16M	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	13.6K	$56.45	$765K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	2.1K	$54.42	$114K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	2.3K	$56.82	$133K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	132	$56.89	$8K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	7.5K	$56.51	$422K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	10.3K	$55.27	$569K	SEC
2024-12-16	Hoffman William	Director	S — Open-market sale [10b5-1]	3.2K	$54.33	$173K	SEC
2024-12-10	Tu Thomas	Chief Medical Officer	S — Open-market sale [10b5-1]	4.0K	$55.00	$220K	SEC
2024-12-01	Silva Karen	Principal Accounting Officer	A — Grant or award	9.2K	$0.00	—	SEC
2024-11-20	Hykes Andrew	President and CEO	S — Open-market sale [10b5-1]	3.0K	$50.83	$152K	SEC
2024-11-18	Hoffman William	Director	S — Open-market sale [10b5-1]	3.0K	$50.09	$150K	SEC
2024-11-18	Hoffman William	Director	S — Open-market sale [10b5-1]	9.8K	$51.16	$499K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Inari Medical, Inc. (NARI). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2024-12-20 — Hykes Andrew (President and CEO)
2024-12-18 — Hoffman William (Director)
2024-12-12 — Tu Thomas (Chief Medical Officer)
2024-12-03 — Silva Karen (Principal Accounting Officer)
2024-11-22 — Hykes Andrew (President and CEO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NARI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

NARI Insider Trading — FAQ

What is the latest insider trade for NARI?: Inari Medical, Inc. (NARI) had 0 insider filings in the last 90 days, with the most recent on 2024-12-20. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying NARI stock?: 0 insider purchases of NARI were filed in the last 90 days.
How many insiders are selling NARI stock?: 0 insider sales of NARI were filed in the last 90 days.
Where can I see NARI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every NARI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live NARI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.